CompoAtlas

Nicorette Lozenge 2 mg

Originaltext auf Französisch.

In Kanada zugelassenes natürliches Gesundheitsprodukt

Die Analyse oraler Dosen ist ohne einen nachgewiesenen ausschließlich oralen Verabreichungsweg nicht anwendbar.

Zusammensetzung

Arzneilicher Inhaltsstoff und QuelleJe Dosiseinheit laut Quelle
Résinate de nicotine

Quelle : Nicotine resinate

Stärke : 2 mg Nicotine

2 mg

Nicht arzneiliche Inhaltsstoffe

Mannitol, Poly(sorbate) 80, Dioxyde de titane, Stéarate de magnésium, Cellulose microcristalline, Saveur de menthe, Pigments nacrés à base de mica, Acésulfame potassium, Carbonate de sodium, Gomme de xanthane, Eau purifiée, Sucralose, Hypromellose, Gomme arabique (acacia)

In Kanada empfohlene Dosen

BevölkerungsgruppeAlterMenge pro EinnahmeHäufigkeit
Adultesminimum : 18 ans1 Pastille15 Tous les jours

In Kanada zugelassene Verwendungen

Nicorette Lozenge is a medicine that can help you stop smoking by reducing withdrawal symptoms and nicotine cravings. Nicorette Lozenge is a form of Nicotine Replacement Therapy (NRT) that can help double your chances of quitting successfully. Nicorette Lozenge provides a lower level of nicotine to your blood than cigarettes and allows you to slowly decrease your body's need for nicotine. It works as a temporary aid to help you quit smoking by reducing nicotine withdrawal symptoms such as irritability, frustration, anxiety, difficulty in concentration and restlessness. Without these powerful urges for the cigarettes you "need", getting rid of the "habit" cigarettes becomes much easier. The good news is that Nicorette Lozenge contains no tar or carbon monoxide, and therefore doesn't present the same medical risks as cigarettes.Nicorette Lozenge can be used to quit immediately or to quit gradually by reducing the number of cigarettes you smoke each day before making a quit attempt.Although smoking cessation is preferable, it can also be used in cases in which you temporarily refrain from smoking, for example, in smoke-free areas or in other situations when you wish to avoid smoking.Combination Nicotine Replacement Therapy: patch + as needed lozenge versus the nicotine patch or lozenge alone is: clinically proven to increase your chances of quitting; a clinically proven approach to increase your chances of quitting. If you have relapsed or experience tough/intense cravings or failed with lozenge alone, you can use Nicorette Lozenge with the patch at the same time to increase your chances of quit success. Now you can have the combined support of Nicoderm patch and Nicorette as needed lozenge products together, for a successful quit.Tackle cravings: Nicoderm patch for slow release constant support and Nicorette as needed lozenge for an extra quick fix/dose when you really need to fight back the cravings/when something triggers intense cravings.Combination therapy is 18%/1.18x more effective than using one Nicotine Replacement Therapy product alone.Use Nicoderm patch + Nicorette Lozenge together to increase your chance of quitting.

Originaltext auf Englisch.

Eine in Kanada zugelassene Verwendung ist keine in der Europäischen Union zugelassene gesundheitsbezogene Angabe. Beachten Sie das Register gesundheitsbezogener Angaben.

Warnhinweise in Kanada

Contra-Indications : Do not use if you are: pregnant or breast feeding, unless you have consulted with a doctor or pharmacist before using this product; under 18 years of age; an occasional or non-smoker or are allergic to nicotine or to any of the non-medicinal ingredients in the product.

Originaltext auf Englisch.

Known Adverse Reactions : For some people, the nicotine in Nicorette Lozenge can occasionally cause mouth or throat irritation but most people get used to this with ongoing use. It can also cause headaches, nausea, hiccups, upset stomach or dizziness. Most of these side effects occur when you first start taking the product and depend on how much you are using. If you have used too many lozenges, you may develop symptoms of overdose such as nausea/upset stomach, drooling, headache, abdominal pain, vomiting, diarrhea, cold sweat, dizziness, disturbed hearing and vision, mental confusion, marked weakness, fainting, rapid heartbeat or difficulty breathing. At high doses, these symptoms may be followed by low blood pressure, weak and irregular pulse, breathing difficulties, extreme exhaustion, circulatory collapse and general convulsions. These aren't ordinary lozenges. Some people get a hot, peppery or tingling sensation; this is just a sign the lozenges are working.

Originaltext auf Englisch.

Cautions and Warnings : WARNING: Nicotine is highly addictive. Ask a doctor before use if you have/had: heart, thyroid or stomach problems, stomach ulcer or esophagitis, throat, mouth or dental problems; angina, coronary artery disease, high blood pressure, a history of epilepsy or seizures, irregular heartbeat, peripheral vascular disease; kidney or liver problems, a tumour of the adrenal gland (phaeochromocytoma), treatment for circulation disorders of the brain. Check with your doctor or pharmacist if you are taking insulin or any prescription medicine; the dose of your prescription medicine may need to be adjusted. If you have diabetes, you may need to monitor your blood sugar levels more closely than normal when you stop smoking and start using this product. Stop using Nicorette Lozenge and consult your doctor if: mouth problems occur, chest pain or leg pain occurs, irregular heartbeat or palpitations occur, or if severe persistent stomach upset (indigestion, heartburn) develops, or if symptoms persist or get worse, or if new symptoms occur. Keep out of reach of children and pets. In case of overdose, contact a Poison Control Centre right away.

Originaltext auf Englisch.

Produktdaten

Inhaber
Kenvue Canada Inc.
NPN oder DIN-HM
80110858
Status
Aktive Lizenz
Lizenzdatum
21. Juni 2021
Überarbeitungsdatum
8. Dezember 2025
Form
Pastille
Verabreichungsweg
Buccale
Art des Antrags
Générale (non traditionelle)

Quelle

Amtlicher Health-Canada-Eintrag, Zulassung 80110858

Licensed Natural Health Products Database (LNHPD), Health Canada: zugelassene Produkte, Inhaltsstoffe, Dosierungen, Verwendungen und Warnhinweise, abgerufen am 27. Oktober 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Originaltext auf Englisch.

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

Originaltext auf Französisch.

Die unter demselben Namen in Europa verkaufte Rezeptur kann abweichen. Diese Angaben ersetzen keinen ärztlichen oder pharmazeutischen Rat.

Liste in der amtlichen Überarbeitung vom (Register: Licensed Natural Health Products Database (LNHPD), Health Canada: zugelassene Produkte, Inhaltsstoffe, Dosierungen, Verwendungen und Warnhinweise).

Das Produkt hat sich geändert? Fotografieren Sie die Verpackung.

Ist eine Angabe zu diesem Produkt falsch oder veraltet, ob Sie Leser oder Marke sind? Schreiben Sie an contact@compoatlas.com: Jede Korrektur wird im Korrekturprotokoll veröffentlicht.

Eingabetaste zum Analysieren, Umschalt+Eingabetaste für eine neue Zeile